EN IT

REGN — Regeneron Pharmaceuticals, Inc. | Setup 20-24 Jul 2026

REGN
Regeneron Pharmaceuticals, Inc.
Technical analysis updated on: 2026-07-25 · [ 20-24 Jul 2026 ] - Copyright AiTrading67.com
📅 Earnings · Jul 30, 2026 · in 5d
Stock · US
Inside composite NTZ, transitioning bias
SCORE IQS Lite
36/100
Compressed phaseCompressed Ordinary phaseOrdinary Stretched phaseStretched Mature phaseMature
Weekly Structure 9
Daily Momentum 19
Weekly Ichimoku 5
Daily CMF 3
Delta 0
IQS Lite components · score
STRUCTURE9/30MOMENTUM19/35ICHIMOKU5/19CMF3/6DELTA0/10

IQS Lite analysis - AiTrading67.com · Regeneron Pharmaceuticals, Inc. (REGN · ISIN US75886F1075)

Weekly Structure
At 9/30 structure is developing: moving averages only partly aligned, trend unconfirmed.
Daily Momentum
At 19/35 momentum is positive: impulse building, daily trend accelerating.
Weekly Ichimoku
At 5/19 Ichimoku is neutral: price inside the cloud, lines unsupportive, no bias.
Daily CMF
At 3/6 CMF is neutral: balance between capital inflows and outflows.
Delta
At 0/10 the week is sharply down: weekly performance below -2%.
Concise reading of each axis score · sum = IQS Lite (0-100)
Executive View
Our view last week
Consolidation reflects structural indecision. The stretched IQS indicates cycle under tension; daily MACD shows bullish fading with inflows remaining present. Awaiting confirmed breakout above NTZ_sup remains the privileged scenario.
This week's view by AiTrading67.com
REGN consolidates inside the NTZ between 639.18 and 672.84 on an ordinary cycle phase. Daily MACD expresses strong bearish weakness limiting short-term momentum, while weekly bearish fading hints at a potential slowdown. Await confirmed breakout before activating new entry setups.
Chart · 12-month trend
Charts provided by TradingView

Full in-depth analysis with precise levels and trade setup is reserved for ★ GOLD
Share WhatsApp Telegram Gmail LinkedIn